Format

Send to

Choose Destination
Eur Respir Rev. 2011 Jun;20(120):114-7. doi: 10.1183/09059180.00001811.

Follow-up and nonpharmacological management of the idiopathic pulmonary fibrosis patient.

Author information

1
Advanced Lung Disease Programme, Mater Misericordiae University Hospital, Eccles Street, Dublin 7, Ireland. jegan@mater.ie

Abstract

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fatal form of diffuse interstitial lung disease. Management of IPF requires an orderly approach, with regular evaluations and implementation of both pharmacological and nonpharmacological treatments. Pulmonary rehabilitation can relieve patients from the distressing symptoms of IPF and improve quality of life. Oxygen therapy is central to treatment of all patients. Lung transplantation enhances survival in selected patients. Mechanical ventilation may be used in patients with acute exacerbations, but the prognosis is poor in these cases. Palliative care focuses on symptom management, advance directives and end-of-life planning. Patient support groups may also play an important role.

PMID:
21632799
DOI:
10.1183/09059180.00001811
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center